PP
TBIO

Paloma Partners’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Paloma Partners’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-11,552
Closed -$94K – 2321
2019
Q4 		$94K Buy
+11,552
New +$107K ﹤0.01% 2055

Other funds holding TBIO

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Paloma Partners's TBIO Position: Q1 2020 in Review

Paloma Partners sold out of Translate Bio, Inc. Common Stock (TBIO) in Q1 2020, closing a stake of 11,552 shares — an estimated $94K sold.

Paloma Partners first reported a position in TBIO in Q4 2019 and held it in 1 quarter. The position peaked at $94K in Q4 2019. 74 funds tracked by Wall St. Rank hold TBIO as of Q1 2020.

  • Paloma Partners reported no remaining Translate Bio, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Paloma Partners sold 11,552 Translate Bio, Inc. Common Stock shares in Q1 2020, an estimated $94K.
  • Paloma Partners first reported a position in Translate Bio, Inc. Common Stock in Q4 2019 and held it in 1 quarter.
  • Paloma Partners's Translate Bio, Inc. Common Stock position peaked at $94K in Q4 2019.
  • 74 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q1 2020.

Based on Paloma Partners's 13F filing for Q1 2020, filed 15 May 2020.